FDA Panel Recommends That Cough Medications Should Stay As Over-The-Counter Drugs

COLLEGE PARK, Md. (EGMN) – A Food and Drug Administration panel on Sept. 14 voted 15 to 9 against requiring that the cough suppressant dextromethorphan be scheduled under the Controlled Substances Act.